Atlas Trials

Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia

Clinical trial NCT01485224 · COMPLETED

Trial details

NCT number
NCT01485224
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hereditary Hemorrhagic TelangiectasiaEpistaxis
Start date
2011-11-01
Primary completion
2014-10-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.